Exploring the potential of Arbacia lixula coelomic fluid peptides as cell cycle and angiogenesis inhibitor for triple-negative breast cancer therapy: In silico study

Context: Triple-negative breast cancer (TNBC) is a breast malignancy with a high degree of heterogeneity. Currently, low treatment efficacy remains a challenge in dealing with TNBC. Arbacia lixula has the potential to become a new therapeutic agent in TNBC. Aims: To analyze the toxicity, allergen...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Dessy Arisanty, Kevin N. Cuandra, Andani E. Putra, Rauza S. Rita, Cimi Ilmiawati, Fika T. Anggraini
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	GarVal Editorial Ltda. 2025-01-01
Sarja:	Journal of Pharmacy & Pharmacognosy Research
Aiheet:	allergenicity arbacia lixula molecular docking toxicity triple-negative breast cancer
Linkit:	https://jppres.com/jppres/pdf/vol13/jppres24.1991_13.1.242.pdf
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!